Premium
Prophylaxis with high‐dose methotrexate significantly reduces CNS dissemination in patients with diffuse large B ‐cell lymphoma ( DLBCL ) and high‐risk CNS‐IPI score
Author(s) -
Ferreri A.J.,
Calimeri T.,
Cecchetti C.,
Vignati A.,
Sassone M.,
Perrone S.,
Girlanda S.,
Ponzoni M.,
Foppoli M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_60
Subject(s) - medicine , diffuse large b cell lymphoma , rituximab , methotrexate , lymphoma , oncology , gastroenterology